Objectives: Viral bronchiolitis is an acute infection and inflammatory disease of the
respiratory tract, with infants typically presenting with the most severe symptoms. Medical …

Purpose High-flow nasal cannula (HFNC) therapy is increasingly proposed as first-line
respiratory support for infants with acute viral bronchiolitis (AVB). Most teams use 2 L/kg/min …

OBJECTIVES: To determine whether the introduction of heated humidified high-flow nasal
cannulae (HFNC) therapy was associated with decreased rates of intubation for infants< 24 …

Background Viral bronchiolitis is the leading cause of hospitalization in children during the
first 12 months of life. There is evidence to support the use of noninvasive ventilation in …

Objectives: Initial respiratory support with noninvasive positive pressure ventilation or high-
flow nasal cannula may prevent the need for invasive mechanical ventilation in PICU …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

OBJECTIVE: To assess the association of the introduction of a high-flow nasal cannula
(HFNC) protocol with clinical outcomes and hospital charges of infants with bronchiolitis …

Purpose Nasal continuous positive airway pressure (nCPAP) is currently the gold standard
for respiratory support for moderate to severe acute viral bronchiolitis (AVB). Although …

Objective: High-flow nasal cannula (HFNC) therapy is increasingly used in paediatric
intensive care unit (PICU) patients, despite a paucity of studies. We describe its use over the …